ACE2 and COVID-19: These metabolic and renal biomarkers—low citric acid, proteinuria, aminoaciduria, elevated ACE2, and ketone bodies—highlight the complex interplay of mitochondrial dysfunction, inflammation, and renal impairment in COVID-19.